Invention Grant
- Patent Title: Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers
-
Application No.: US16438886Application Date: 2019-06-12
-
Publication No.: US11572413B2Publication Date: 2023-02-07
- Inventor: Myron Arlen , J. Andrew Bristol , Ariel Hollinshead , Kwong Tsang
- Applicant: PRECISION BIOLOGICS, INC.
- Applicant Address: US MD Rockville
- Assignee: PRECISION BIOLOGICS, INC.
- Current Assignee: PRECISION BIOLOGICS, INC.
- Current Assignee Address: US MD Rockville
- Agency: Baker, Donelson, Bearman, Caldwell & Berkowitz PC
- Agent Robin L. Teskin
- Main IPC: C07K16/30
- IPC: C07K16/30 ; A61K39/395 ; A61K45/06 ; C07H21/04 ; A61K39/00
Abstract:
The present invention provides for purified or highly pure recombinant monoclonal antibodies that bind to human colorectal and pancreatic carcinoma-associated antigens (CPAA), along with nucleic acid sequences encoding the antibody chains, and the amino acid sequences corresponding to said nucleic acids and uses for said sequences.
Public/Granted literature
- US20190322759A1 RECOMBINANT MONOCLONAL ANTIBODIES AND CORRESPONDING ANTIGENS FOR COLON AND PANCREATIC CANCERS Public/Granted day:2019-10-24
Information query
